The Valley Desk

Clinical trial reportThe international journal of neuropsychopharmacologyPublished

Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
The international journal of neuropsychopharmacology
Published
Subject terms
Humans; Ketamine; Antidepressive Agents; Treatment Outcome; Drug Therapy, Combination; Administration, Intranasal; Adult; Aged; Middle Aged; Female; Male; Nasal Sprays
PubMed ID
40319349
PubMed Central ID
PMC12143125
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal